Jagsonpal Pharmaceuticals Limited

NSE: JAGSNPHARM BSE: 507789 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

219 1(0%)

Volume

5L as on 23, Jun

Open

649

High

670

Low

637

220

VWAP

230

52 Week High

302

52 Week Low

155

Viand Research Rating

Quality Score

46/100

Growth Score

40/100

Valuation Score

50/100

Momentum Score

25/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,444

No. of Shares

6.71

P/E

74.48

P/B

9.18

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

12.33

ROCE

Profit Growth

Listing Date

01-Mar-00

Promoter Holding

67.89%

FII Holding

2.44%

DII Holding

0.22%

Price Chart

Price Performance

1 Week11%

1 Month10%

3 Months27%

6 Months31%

1 Year31%

YTD31%

Moving Average

5 Day SMA217

10 Day SMA213

20 Day SMA209

30 Day SMA208

50 Day SMA206

61 Day SMA202

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	245	227	237	245
Resistance 2	237	226	231	237
Resistance 1	230	224	227	229
Pivot Point	221	223	221	221
Support 1	214	221	215	214
Support 2	205	220	211	205
Support 3	198	218	205	198

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.51) 67.89%	(-0.21) 67.39%	(-0.11) 67.54%	(-0.11) 67.65%	(0.01) 67.77%	(-0.21) 67.82%	(-0.11) 67.98%	(0.01) 68.04%	(-0.41) 68.09%	(-0.21) 68.48%	(0.01) 68.72%	(0.01) 68.72%	(0.01) 68.72%	(0.01) 68.72%	(0.01) 68.72%	(0.01) 68.71%	(-1.61) 68.71%	(0.01) 70.34%	(0.01) 70.34%
FIIs	(0.31) 2.44%	(0.01) 2.12%	(0.01) 2.12%	(0.11) 2.17%	(0.01) 2.10%	(-0.21) 2.10%	(1.21) 2.30%	(0.41) 1.10%	(0.21) 0.73%	(0.21) 0.53%	(0.01) 0.38%	(0.31) 0.37%	(0.01) 0.10%	(0.01) 0.11%	(0.11) 0.13%	(0.01) 0.00%	(-0.21) 0.00%	(0.11) 0.20%	(0.01) 0.11%
DIIs	(0.11) 0.22%	(0.11) 0.15%	(0.01) 0.08%	(0.11) 0.05%	(0.01) 0.00%	(-0.11) 0.00%	(-0.71) 0.11%	(0.01) 0.84%	(0.01) 0.84%	(0.01) 0.82%	(0.01) 0.82%	(0.01) 0.82%	(0.01) 0.82%	(0.51) 0.77%	(-0.41) 0.28%	(0.01) 0.68%	(0.71) 0.67%	(0.01) 0.00%	(0.01) 0.01%
Public	29.44%	30.34%	30.25%	30.12%	30.11%	30.10%	29.63%	30.01%	30.33%	30.16%	30.07%	30.07%	30.34%	30.40%	30.85%	30.61%	30.61%	29.46%	29.54%
No. of Shareholders	26,264	24,895	24,653	22,899	21,085	18,471	15,633	15,748	16,282	15,785	16,041	13,782	14,084	14,535	14,952	16,194	17,100	20,031	14,353

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	64.2	72.95	74.47	75.61	58.56	74.03	74.69	61.44	43.49	47.23	57.83	60.15	55.45	60	61	61	51.23	54	59	54.05
Sales Growth % (YoY)	-	-	-	-	-	-	-	-	-	-	-	-	-	10.4%	1.8%	12.1%	19.6%	-5%	5.6%	70.8%
Sales Growth % (QoQ)	-12%	-2%	-1.5%	29.1%	-20.9%	-0.9%	21.6%	41.3%	-7.9%	-18.3%	-3.9%	8.5%	-7.6%	-1.6%	-	19.1%	-5.1%	-8.5%	9.2%	-
Expenses	53.04	56.68	58.03	61.41	49.85	58.19	58.4	51.19	40.82	43.83	49.46	51.52	50.01	52	48	53	50.45	49	50	44.77
Operating Profit	11.16	16.27	16.44	14.2	8.71	15.84	16.29	10.25	2.67	3.4	8.37	8.63	5.44	9	13	7	0.78	6	9	9.28
OPM %	17.38	22.3	22.08	18.78	14.87	21.4	21.81	16.68	6.14	7.2	14.47	14.35	9.81	14	21	12	1.52	10	16	17.17
Other Income	3.17	0.9	3.03	2.83	2.56	25.51	1.65	-1.85	2.49	2.52	2.27	2	2.56	2	1	-3	0.37	2	0	0.82
Interest	0.25	0.26	0.27	0.25	0.26	0.26	0.23	0.22	0.22	0.23	0.22	0.15	0.2	0	0	0	0.06	0	0	0.11
Depreciation	2.32	2.39	2.39	2.35	2.31	2.41	2.34	1.07	0.4	0.41	0.46	0.39	0.48	0	0	0	0.65	0	0	0.28
Profit before tax	11.76	14.52	16.81	14.43	8.7	38.68	15.37	7.11	4.54	5.28	9.96	10.09	7.32	10	14	4	0.44	7	9	9.71
Tax %	25.43	24.59	25.22	25.23	24.48	17.27	25.44	25.04	21.59	24.81	25	25.87	23.5	21	24	24	31.82	24	30	29.45
Net Profit	8.76	10.95	12.57	10.8	6.58	31.99	11.46	5.33	3.55	3.96	7.47	7.48	5.6	8	10	3	0.31	5	7	6.85
Net Profit Growth % (QoQ)	-20%	-12.9%	16.4%	64.1%	-79.4%	179.1%	115%	50.1%	-10.4%	-47%	-0.1%	33.6%	-30%	-20%	233.3%	867.7%	-93.8%	-28.6%	2.2%	-
Net Profit Growth % (YoY)	33.1%	-65.8%	9.7%	102.6%	85.4%	707.8%	53.4%	-28.7%	-36.6%	-50.5%	-25.3%	149.3%	1706.5%	60%	42.9%	-56.2%	-	-	-	-
TTM Net Profit	43.08	40.9	61.94	60.83	55.36	52.33	24.3	20.31	22.46	24.51	28.55	31.08	26.6	21.31	18.31	15.31	19.16	18.85	13.85	0
EPS in Rs	1.31	1.64	1.89	1.62	0.99	4.82	1.73	0.81	0.54	0.6	1.14	1.14	0.85	1.19	1.59	0.45	0.05	0.83	1	2.61

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	287	269	209	237	218	188	159	167	127	144	143	138	144	166
Sales Growth %	6.9%	28.8%	-11.8%	8.8%	15.8%	18.5%	-5%	31.8%	-12%	0.3%	3.9%	-4%	-13.6%	-5.7%
Expenses	229	218	186	203	192	169	150	157	138	138	132	129	133	156
Operating Profit	58	51	23	34	26	19	9	9	-11	6	12	9	11	10
OPM %	20	19	11	14	12	10	5	6	-9	4	8	6	7	6
Other Income	10	28	9	2	3	4	3	1	0	13	1	0	0	0
Interest	1	1	1	0	0	1	1	1	1	3	5	4	5	5
Depreciation	9	8	2	1	2	1	1	1	0	2	3	3	3	3
Profit before tax	58	70	30	35	27	22	9	9	-12	14	4	2	3	3
Tax %	25	21	25	23	29	22	16	20	-1	18	20	30	16	28
Net Profit	43	55	22	27	19	17	8	7	-12	12	3	1	2	2
Net Profit Growth %	-21.8%	150%	-18.5%	42.1%	11.8%	112.5%	14.3%	158.3%	-200%	300%	200%	-50%	-	-
EPS in Rs	6.43	8.34	3.4	4.08	2.88	2.6	1.2	1.1	-1.76	1.81	0.5	0.18	0.32	0.28
Dividend Payout %	62	30	59	49	56	15	17	9	-2	2	8	22	62	72

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	47	55	35	47	7	28	11	31	-2	-3	9	4	8	12
Cash from Investing Activity	-36	-45	-25	-58	-26	-2	-11	-1	-3	41	-2	0	-1	-3
Cash from Financing Activity	-12	-12	-9	0	-18	-7	-1	-6	-1	-34	-6	-1	-4	-8
Net Cash Flow	-1	-2	2	-11	-36	19	0	24	-6	5	1	2	2	0

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13
Reserves	263	240	227	184	174	146	120	109	98	91	85	97	85	82	85	85
Borrowings	8	9	9	10	9	6	0	7	5	4	8	8	38	39	36	33
Other Liabilities	32	37	29	51	21	30	31	35	31	28	23	25	22	19	22	21
Total Liabilities	317	299	278	258	217	195	164	164	147	136	130	143	159	154	156	153
Fixed Assets	85	90	94	99	9	24	23	26	22	22	21	22	52	52	56	58
CWIP	0	0	0	0	0	0	0	0	4	4	3	0	0	0	2	2
Investments	0	0	0	0	0	1	51	15	11	0	0	0	0	0	0	0
Other Assets	231	209	184	159	208	170	91	123	109	110	105	121	108	102	98	92
Total Assets	317	299	278	258	217	195	164	164	147	136	130	143	159	154	156	153

Delivery

#	Date	195 36% 264	Value (Cr)	Q/T 58	Del 41	Del 7
1	22-Jul	220	1	32	47	1
2	21-Jul	222	1	28	46	0
3	20-Jul	223	1	30	45	1
4	17-Jul	224	1	9	48	0
5	16-Jul	227	3	28	33	1
6	15-Jul	224	1	29	48	1
7	14-Jul	226	1	23	52	0
8	13-Jul	230	1	26	56	1
9	10-Jul	233	1	25	39	1
10	9-Jul	232	2	32	42	1
11	8-Jul	229	3	32	41	1
12	7-Jul	239	5	31	24	1
13	6-Jul	237	5	44	34	2
14	3-Jul	237	6	41	20	1
15	2-Jul	235	5	37	29	1
16	1-Jul	238	14	49	20	3
17	30-Jun	238	260	106	5	13
18	29-Jun	230	10	48	22	2
19	25-Jun	224	4	49	42	2
20	24-Jun	230	5	47	42	2
21	23-Jun	232	11	56	40	4
22	22-Jun	223	10	45	42	4
23	19-Jun	212	1	20	48	1
24	18-Jun	211	1	30	46	0
25	17-Jun	209	1	36	45	1
26	16-Jun	209	1	41	48	1
27	15-Jun	213	1	33	57	1
28	12-Jun	211	4	44	38	1
29	11-Jun	210	2	39	43	1
30	10-Jun	205	1	11	54	1
31	9-Jun	202	0	28	44	0
32	8-Jun	199	2	39	35	1
33	5-Jun	203	1	28	59	0
34	4-Jun	203	1	32	64	1
35	3-Jun	202	1	34	41	0
36	2-Jun	202	0	41	60	0
37	1-Jun	202	1	37	61	0
38	29-May	207	1	36	56	1
39	27-May	209	4	54	43	2
40	26-May	208	2	36	37	1
41	25-May	206	3	53	60	2
42	22-May	210	4	89	77	3
43	21-May	212	8	62	41	3
44	20-May	199	1	30	45	1
45	19-May	197	1	25	47	1
46	18-May	201	2	32	50	1
47	15-May	206	1	34	59	0
48	14-May	207	1	40	55	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	1,444c	7c	0.48
22-Jul	1,451c	19c	1.30
21-Jul	1,470c	8c	0.56
17-Jul	1,478c	6c	0.41
16-Jul	1,484c	8c	0.52
15-Jul	1,492c	20L	0.01
14-Jul	1,492c	26c	1.69
13-Jul	1,518c	10c	0.64
10-Jul	1,527c	2c	0.16
09-Jul	1,525c	19c	1.25
08-Jul	1,506c	74c	4.66
07-Jul	1,580c	14c	0.88
06-Jul	1,566c	9c	0.56
02-Jul	1,575c	6c	0.40
01-Jul	1,569c	10c	0.63
30-Jun	1,579c	58c	3.80
29-Jun	1,521c	53c	3.60
26-Jun	1,468c	18c	1.22
25-Jun	1,486c	27c	1.77
24-Jun	1,513c	6c	0.37
23-Jun	1,507c	46c	3.14
22-Jun	1,462c	66c	4.69
19-Jun	1,396c	33c	2.40
17-Jun	1,363c	10c	0.72
16-Jun	1,373c	23c	1.64
15-Jun	1,396c	4c	0.31
12-Jun	1,392c	25c	1.85
11-Jun	1,367c	23c	1.71
10-Jun	1,344c	0	0

Stock Checklist

Price is below from 52 week high low average: 12%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: YES

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Jul26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.03%	-	0

Jagsonpal Pharmaceuticals Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements